IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

Colorectal Cancer Laboratory News

Picture of a colon tumour (Author: Eduard Batlle, IRB).
Institutional
Olga Torres Foundation awards IRB Barcelona a grant to study immunotherapies for metastatic colorectal cancer
Open Day 2015.
Outreach
On Saturday IRB Barcelona is to open its doors to citizens interested in cutting-edge biomedicine
Patient derived colorectal cancer in mice with LGR5-enhanced flourescent protein (EGFP) modification to follow the behaviour of cancer stem cells (image: G. Turon, IRB Barcelona)
Scientific
A genome-editing strategy to study cancer stem cells in human tumours
This TECNIO seal recognises the IRB Barcelona's Innovation department as a competitive agent in Catalonia’s innovation system
Innovation
IRB Barcelona Innovation’s “triple” boost from the Catalan Government
Copyright: Getty Images.
Media mentions
Cancer by chance? Do not bet against yourself
Media mentions
IRB Barcelona's European research into cancer
After chemotherapy, quiescent cells change their behaviour​, become active​ ​and regenerate all cell types in the intestine (in green). (F Barriga, IRB Barcelona)
Media mentions
New type of stem cells discovered by IRB Barcelona
Media mentions
Eduard Batlle: "The immune system is more potent than chemotherapy”
In normal intestinal conditions, after three days, quiescent stem cells (​in ​ green) d​on't divide compared to other quickly-dividing intestinal cells​ (in red)​ . (F Barriga, IRB Barcelona)
Media mentions
A reservoir of stem cells in the intestine
After chemotherapy, quiescent cells change their behaviour​, become active​ ​and regenerate all cell types in the intestine (in green). (F Barriga, IRB Barcelona)
Scientific
The intestine has a reservoir of stem cells that are resistant to chemotherapy
Merus N.V. is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics.
Innovation
IRB Barcelona and Merus form a research collaboration to develop antibodies targeting the tumor microenvironment
Media mentions
Eduard Batlle: "Nanomedicine is already providing spectacular solutions"
Media mentions
Eduard Batlle's opinion about studies on genetics
El investigador ICREA Eduard Batlle lidera uno de los paquetes de trabajo de SUPPRESSTEM
Media mentions
Eduard Batlle wins the 2016 Carmen and Severo Ochoa Prize
Eduard Batlle, Carmen and Severo Ochoa Prize 2016
Innovation
IRB Barcelona scientist Eduard Batlle wins the 2016 Carmen and Severo Ochoa Prize
Institutional
International experts debate the most recent breakthroughs in oncology at the CosmoCaixa
Media mentions
10 lines of investigation to light up Researchers’ Night
34 researchers have been awarded in the 2016 edition. Today, all the attendees at the ceremony in the AECC institutional act held in Barcelona (Picture: AECC)
Institutional
The AECC supports cancer research at IRB Barcelona
Media mentions
Preventing metastasis starting with a colon cancer diagnosis
(From left to right): Dr José Antonio Gutiérrez, Lilly Foundation honorary advisor; awardees Dr Luis Alberto Moreno Aznar and Dr Eduard Batlle; and Dr José Antonio Sacristán, director of the Lilly Foundation
Institutional
Eduard Batlle, Lilly Foundation Prize: “In five years’ time we will have treatments for colon cancer metastasis”
(from left to right) Dr Castells, Dr Eduard Batlle, Dr Elena Élez, and chair Josep Corbella, health journalist at La Vanguardia (A Ros, IRB Barcelona)
Institutional
Eduard Batlle: “The immune system is incredibly powerful against tumours”
Media mentions
Eduard Batlle: "As a child I dreamed of being Han Solo and piloting the Millennium Falcon"
Media mentions
Eduard Batlle receives Lilly's Biomedical Research Award
Institutional
Eduard Batlle awarded the Lilly Foundation's 2016 Biomedical Research Award
Media mentions
A high-fat diet increases the risk of colon cancer
Institutional
AECC funds an IRB Barcelona cancer research project through the "Carmen Lavigne" Prize
Images taken from the virtual experiment developed by XPlore Health in collaboration with IRB Barcelona
Institutional
"Study a cure for bowel cancer”, a new online experiment by Xplore Health
Innovation
The biomedicine boom
Media mentions
“It is necessary to invest in research even during a crisis”
Media mentions
Eduard Batlle: "CRISPR/Cas9 is a truly cutting-edge technique for biomedicine”